All Activities

Ned Amendola, MD

• Path

Snow B. Daws, MD

• Path

Justin Fleming, DPM

• Path

Jesse Doty, MD

• Path

Stephen Brockmeier, MD

• Path

Michael G. Baraga, MD

• Path

Thomas R. Carter, MD

• Path

Vic Goradia, MD

• Path

Laith M. Jazrawi, MD

• Path

Steve E. Jordan, MD

• Path

Andrew J. Rosenbaum, MD

• Path

Andy P. Hartman, MD

• Path

Meniscal Pathologies: Literature Review on All-Inside Meniscal Repair Outcomes

Rachel M. Frank, MD (Denver, CO), discusses patient outcome data for all-inside meniscal repair. Dr. Frank also reviews comparative biomechanical results between all-inside and inside-out repairs of vertical longitudinal meniscus tears.

• Duration 9m

Asghar Husain, MD

• Path

Kelsey Millonig, DPM

• Path

Jason M. Scopp, MD

• Path

Kevin Kruse, MD

• Path

Meniscal Pathologies: Literature Review on Biomechanical Results of Various Meniscal Repair Techniques

Christopher Adams, MD (Arthrex Senior Vice President of Medical Affairs), leads a discussion with Aaron J. Krych, MD (Rochester, MN); Travis G. Maak, MD (Salt Lake City, UT); and Patrick A. Smith, MD (Columbia, MO), about a biomechanical study published...

• Duration 4m

Alan Catanzariti, DPM

• Path

John T. Riehl, MD

• Path

Hip Arthroscopy Essentials: Overview of Hip Joint Access

Benjamin G. Domb, MD (Chicago, IL), provides an overview of hip joint access, featuring the Synergy Extended-Length Hip Arthroscope System.

• Duration 15m

Treatment Considerations for Intertrochanteric Femur Fractures

At the Sports Medicine Fellows Forum, Sean P. Calloway, MD (Indianapolis, IN), provides a case-based discussion regarding clinical considerations for evaluating and treating intertrochanteric femur fractures.

• Duration 8m

Flatfoot Deformities

• Path

Spine Evolutions: Incorporating Biologics Into Your Fusions

Andrew Clavenna, MD (Dallas, TX), describes the various orthobiologics that can be incorporated into spinal fusions. Dr. Clavenna also discusses the optimal harvesting of bone marrow aspirate, which enables the harvest of osteoprogenitor cells.

• Duration 9m